Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
eNq1mFFv2jAQx9/5FFHeSQK0JZ0C1cbaDWnVGC3atBdkkqOYuXZ6doDu088hVKWTo7YGv0Hs/O/i+/vnk5OLzT3zVoCSCt7zW0Hke8BTkVF+1/Mnt1fN2L/oN5IlWZHnaW09L2i1fC9lRMqeX44GMyBcBr+uv30G/T6g3294iZgtIVUv5hWKsuArkYtrkpdzvGQlaObdg1qIrOfnhdo+9RKpUGfRXwv8I3OSQhLunuyPLqcn+8+TsBR7g2ohAb8RfmcUnaOVZlogAlcDouBO4KNZOp224+5ZFMVWIagcgxQFpjAiajFCsaIZZOZIhEmwCjJfZzeAKwaqDGIUD5fpvbQSJ0uyGcPD0Jz0Rz06UBvVjJqtbnwSRa12Jzo771qFwr2lMptHf0SY55hN2+fxaSfuhnMMMxQMckV4U//KAWkmmGWtRgIVYY6qROXgpd8cxUF4eNUNGZU5I4/BUua2S0WQ6GFATQV3H1J+wS1qTjG9Zv/p84Kx8J1ZT3YUcZRxCamBKLiqgcnV2HYhBoIr2NRX1I5/arPzIgV5PNm/gpvZPypmjKa2iNMQKkCqyXhYTziXcPhEJEzQHR1+Up6JtTw+dfar7Cj7fAtOo2g+7USn8XnH/tj/rf1Uc/xcFmVVQw0jKg9hzJDPxaF00RY1Sz0Z1Jk3t72RSAmDmu6oaQkebcqnZs6Z7d1tqWrAKPrl8tbWLj8KwMeb7V+jNM16+4W2A7ML2mt/vpZ7tY17h23ZSuQNTfVJ3Gnb+R3NqFkolcsPYbher4MFkU1J9DIGeqe9+Wi4OMoKaOY+F9Bdz++kJ6h6pAq5jlKfVQfp+0pou11f6xoO7YR37+86bmMMhQUcUIuK7M74O7w8PtKf22BnaY9eUMZdmG3LShQV3FXrVMzMLD70ENGl5VeoGfF9Pqc1tzG11kzC6iao30jC8hao3/gHVzkSeQ==
McNxK8mwx5GKuCpZ